Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals.

In English

Författare

  • Cristina Maglio
  • Ulrika Ericson
  • Maria Antonella Burza
  • Rosellina Margherita Mancina
  • Carlo Pirazzi
  • Johanna Andersson Assarsson
  • Kajsa Sjöholm
  • Marco Giorgio Baroni
  • Per-Arne Svensson
  • Tiziana Montalcini
  • Arturo Pujia
  • Lars Sjöström
  • Olov Wiklund
  • Lena Carlsson
  • Jan Borén
  • Marju Orho-Melander
  • Stefano Romeo
Visa allt

Summary, in English

Context:Obesity and insulin resistance are risk factors for cancer development. The IRS1 rs2943641 genetic variant has been widely associated with insulin resistance.Objective:The aim of the study was to examine whether the IRS1 rs2943641 associates with cancer incidence in obese individuals.Design, Setting and Patients:The IRS1 rs2943641 was genotyped in participants from the Swedish Obese Subjects (SOS) study, an intervention trial on the effect of bariatric surgery on mortality and morbidity compared with usual care and in the population-based Malmö Diet and Cancer (MDC) cohort. In both studies, the median follow-up for cancer incidence was about 15 years.Intervention and Main Outcome Measure:Cancer incidence was assessed in both the SOS and the MDC cohorts through national and local registers.Results:The IRS1 T allele was associated with lower insulin resistance in both the SOS and the MDC studies. A lower cancer incidence was found in T allele carriers from the SOS control group (hazard ratio [HR] 0.77, 95% confidence interval [CI] 0.62-0.96; P = .021) and was restricted to morbidly obese individuals (HR 0.67, 95% CI 0.50-0.91; P = .011). No evidence of such association was detected in the surgery group (interaction P = .005). In the MDC cohort, a nonsignificant tendency for lower cancer incidence in T allele carriers was observed only in morbidly obese individuals. A meta-analysis of morbidly obese individuals (body mass index > 40 kg/m(2)) from the two cohorts strengthened the evidence for the association (HR 0.66, 95% CI 0.50-0.87; P = .004).Conclusions:Our results suggest that the T allele of rs2943641 near IRS1 may associate with lower cancer incidence in morbidly obese individuals.

Publiceringsår

2013

Språk

Engelska

Sidor

785-789

Publikation/Tidskrift/Serie

Journal of Clinical Endocrinology and Metabolism

Volym

98

Issue

4

Dokumenttyp

Artikel i tidskrift

Förlag

Oxford University Press

Ämne

  • Endocrinology and Diabetes

Status

Published

Forskningsgrupp

  • Diabetes - Cardiovascular Disease

ISBN/ISSN/Övrigt

  • ISSN: 1945-7197